Mach-1 Financial Group’s DexCom DXCM Stock Holding History

Mach-1 Financial Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,010	Closed	-$746K	–	122
2023 Q4	$746K	Buy	+6,010	New	+$614K	0.28%	80

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mach-1 Financial Group's DXCM Position: Q1 2024 in Review

Mach-1 Financial Group sold out of DexCom (DXCM) in Q1 2024, closing a stake of 6,010 shares — an estimated $746K sold.

Mach-1 Financial Group first reported a position in DXCM in Q4 2023 and held it in 1 quarter. The position peaked at $746K in Q4 2023. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

Mach-1 Financial Group reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
Mach-1 Financial Group sold 6,010 DexCom shares in Q1 2024, an estimated $746K.
Mach-1 Financial Group first reported a position in DexCom in Q4 2023 and held it in 1 quarter.
Mach-1 Financial Group's DexCom position peaked at $746K in Q4 2023.
1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Mach-1 Financial Group's 13F filing for Q1 2024, filed 10 May 2024.